Nutrition Research and Practice

The Korean Nutrition Society (한국영양학회)
권호 표지
DOI QR코드

DOI QR Code

Extracts of Grifola frondosa inhibit the MAPK signaling pathways involved in keratinocyte inflammation and ameliorate atopic dermatitis

  • Eun-Ju Choi (Department of Physical Education, College of Education, Daegu Catholic University) ;
  • Jin Kyeong Choi (Department of Immunology, Jeonbuk National University Medical School)
  • Received : 2023.09.20
  • Accepted : 2023.11.02
  • Published : 2023.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

BACKGROUND/OBJECTIVES: Grifola frondosa, commonly referred to as the maitake mushroom, has been studied extensively to explore its potential health benefits. However, its anti-inflammatory effects in skin disorders have not been sufficiently elucidated. This study aimed to elucidate the anti-inflammatory role of the ethanol extract of G. frondosa in atopic dermatitis (AD) using in vivo and in vitro models. MATERIALS/METHODS: We investigated its impact on skin and spleen inflammatory responses in Dermatophagoides farinae extract (DFE)/1-chloro-2,4 dinitrochlorobenzene (DNCB)-induced AD-like skin lesions in a mouse model. Additionally, we determined the immunosuppressive response and mechanism of G. frondosa by inducing atopic-like immune reactions in keratinocytes through tumor necrosis factor (TNF)-α/interferon (IFN)-γ stimulation. RESULTS: Our study revealed that G. frondosa ameliorates clinical symptoms in an AD-like mouse model. These effects contributed to the suppression of Th1, Th2, Th17, and Th22 immune responses in the skin and spleen, leading to protection against cutaneous inflammation. Furthermore, G. frondosa inhibited the production of antibodies immunoglobulin (Ig)E and IgG2a in the serum of AD mice. Importantly, the inhibitory effect of G. frondosa on inflammatory cytokines in TNF-α/IFN-γ-stimulated AD-like keratinocytes was associated with the suppression of MAPK (Mitogen Activated Protein Kinase) pathway activation. CONCLUSIONS: Collectively, these findings highlight the potential of G. frondosa as a novel therapeutic agent for AD treatment and prevention.

Keywords

Acknowledgement

This paper was supported by research funds for newly appointed professors of Jeonbuk National University in 2020, BK21FOUR 21st Century of Medical Science Creative Human Resource Development Center, and a National Research Foundation of Korea grant funded by the Korean government (2022R1F1A1074651).

References

  1. Sidler D, Wu P, Herro R, Claus M, Wolf D, Kawakami Y, Kawakami T, Burkly L, Croft M. TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis. Nat Commun 2017;8:15395.
  2. Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov 2022;21:21-40. https://doi.org/10.1038/s41573-021-00266-6
  3. Silverberg JI, Boguniewicz M, Hanifin J, Papp KA, Zhang H, Rossi AB, Levit NA. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis is efficacious regardless of age of disease onset: a post hoc analysis of two phase 3 clinical trials. Dermatol Ther (Heidelb) 2022;12:2731-46. https://doi.org/10.1007/s13555-022-00822-x
  4. Debnath T, Kim DH, Lim BO. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease. Molecules 2013;18:7253-70. https://doi.org/10.3390/molecules18067253
  5. Wu S, Pang Y, He Y, Zhang X, Peng L, Guo J, Zeng J. A comprehensive review of natural products against atopic dermatitis: flavonoids, alkaloids, terpenes, glycosides and other compounds. Biomed Pharmacother 2021;140:111741.
  6. Sullivan R, Smith JE, Rowan NJ. Medicinal mushrooms and cancer therapy: translating a traditional practice into Western medicine. Perspect Biol Med 2006;49:159-70. https://doi.org/10.1353/pbm.2006.0034
  7. Valverde ME, Hernandez-Perez T, Paredes-Lopez O. Edible mushrooms: improving human health and promoting quality life. Int J Microbiol 2015;2015:376387.
  8. Liu J, Wu Y, Cai Y, Tan Z, Deng N. Long-term consumption of different doses of Grifola frondosa affects immunity and metabolism: correlation with intestinal mucosal microbiota and blood lipids. 3 Biotech 2023;13:189.
  9. Dai R, Liu M, Nik Nabil WN, Xi Z, Xu H. Mycomedicine: a unique class of natural products with potent anti-tumour bioactivities. Molecules 2021;26:26.
  10. Hu R. Grifola frondosa may play an anti-obesity role by affecting intestinal microbiota to increase the production of short-chain fatty acids. Front Endocrinol (Lausanne) 2023;13:1105073.
  11. Tripodi F, Falletta E, Leri M, Angeloni C, Beghelli D, Giusti L, Milanesi R, Sampaio-Marques B, Ludovico P, Goppa L, et al. Anti-aging and neuroprotective properties of Grifola frondosa and Hericium erinaceus extracts. Nutrients 2022;14:14.
  12. Kim JH, Lim SR, Jung DH, Kim EJ, Sung J, Kim SC, Choi CH, Kang JW, Lee SJ. Grifola frondosa extract containing bioactive components blocks skin fibroblastic inflammation and cytotoxicity caused by endocrine disrupting chemical, bisphenol A. Nutrients 2022;14:14.
  13. Choi JK, Jang YH, Lee S, Lee SR, Choi YA, Jin M, Choi JH, Park JH, Park PH, Choi H, et al. Chrysin attenuates atopic dermatitis by suppressing inflammation of keratinocytes. Food Chem Toxicol 2017;110:142-50. https://doi.org/10.1016/j.fct.2017.10.025
  14. Mathlouthi M, Koenig JL. Vibrational spectra of carbohydrates. Adv Carbohydr Chem Biochem 1986;44:7-89. https://doi.org/10.1016/S0065-2318(08)60077-3
  15. Lee KJ, Ratih K, Kim GJ, Lee YR, Shin JS, Chung KH, Choi EJ, Kim EK, An JH. Immunomodulatory and anti-inflammatory efficacy of hederagenin-coated maghemite (γ-Fe2O3) nanoparticles in an atopic dermatitis model. Colloids Surf B Biointerfaces 2022;210:112244.
  16. Laughter MR, Maymone MB, Mashayekhi S, Arents BW, Karimkhani C, Langan SM, Dellavalle RP, Flohr C. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017. Br J Dermatol 2021;184:304-9. https://doi.org/10.1111/bjd.19580
  17. Firacative C, Gressler AE, Schubert K, Schulze B, Muller U, Brombacher F, von Bergen M, Alber G. Identification of T helper (Th)1- and Th2-associated antigens of Cryptococcus neoformans in a murine model of pulmonary infection. Sci Rep 2018;8:2681.
  18. Lim JS, Kim JY, Lee S, Choi JK, Kim EN, Choi YA, Jang YH, Jeong GS, Kim SH. Bakuchicin attenuates atopic skin inflammation. Biomed Pharmacother 2020;129:110466.
  19. Bunikowski R, Gerhold K, Brautigam M, Hamelmann E, Renz H, Wahn U. Effect of low-dose cyclosporin a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. Int Arch Allergy Immunol 2001;125:344-8. https://doi.org/10.1159/000053836
  20. Choi JK, Kim SH. Inhibitory effect of galangin on atopic dermatitis-like skin lesions. Food Chem Toxicol 2014;68:135-41. https://doi.org/10.1016/j.fct.2014.03.021
  21. Xu X, Liu Y, Pan C, Han S, Ma L, Qiao Y, Shi B, Peng Q. Antioxidant and immunomodulatory activities of polysaccharides from fermented wheat products of Grifola frondosa: in vitro methods. Int J Food Sci 2023;2023:3820276.
  22. Tomas-Hernandez S, Blanco J, Garcia-Vallve S, Pujadas G, Ojeda-Montes MJ, Gimeno A, Arola L, Minghetti L, Beltran-Debon R, Mulero M. Anti-inflammatory and immunomodulatory effects of the Grifola frondosa natural compound o-orsellinaldehyde on LPS-challenged murine primary glial cells. Roles of NF-κβ and MAPK. Pharmaceutics 2021;13:806.
  23. Geng J, Wang G, Guo J, Han X, Qu Y, Zhou Y, Tai G, Sun L, Cheng H. Preparation and structural analysis of fucomannogalactan and β-1,6-glucan from Grifola frondosa mycelium. Front Chem 2023;11:1227288.
  24. Vetter J. The mushroom glucans: molecules of high biological and medicinal importance. Foods 2023;12:1009.
  25. Wu JY, Siu KC, Geng P. Bioactive ingredients and medicinal values of Grifola frondosa (Maitake). Foods 2021;10:95.
  26. Jesenak M, Urbancek S, Majtan J, Banovcin P, Hercogova J. β-Glucan-based cream (containing pleuran isolated from pleurotus ostreatus) in supportive treatment of mild-to-moderate atopic dermatitis. J Dermatolog Treat 2016;27:351-4. https://doi.org/10.3109/09546634.2015.1117565
  27. Meng J, Li Y, Fischer MJ, Steinhoff M, Chen W, Wang J. Th2 modulation of transient receptor potential channels: an unmet therapeutic intervention for atopic dermatitis. Front Immunol 2021;12:696784.
  28. Mohd Zaid NA, Sekar M, Bonam SR, Gan SH, Lum PT, Begum MY, Mat Rani NN, Vaijanathappa J, Wu YS, Subramaniyan V, et al. Promising natural products in new drug design, development, and therapy for skin disorders: an overview of scientific evidence and understanding their mechanism of action. Drug Des Devel Ther 2022;16:23-66. https://doi.org/10.2147/DDDT.S326332
  29. Moens L, Tangye SG. Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage. Front Immunol 2014;5:65.
  30. Bieber T. Atopic dermatitis. Ann Dermatol 2010;22:125-37. https://doi.org/10.5021/ad.2010.22.2.125
  31. Chieosilapatham P, Kiatsurayanon C, Umehara Y, Trujillo-Paez JV, Peng G, Yue H, Nguyen LT, Niyonsaba F. Keratinocytes: innate immune cells in atopic dermatitis. Clin Exp Immunol 2021;204:296-309. https://doi.org/10.1111/cei.13575
  32. Rerknimitr P, Otsuka A, Nakashima C, Kabashima K. The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus. Inflamm Regen 2017;37:14.
  33. Homey B, Steinhoff M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006;118:178-89. https://doi.org/10.1016/j.jaci.2006.03.047
  34. Kim SY, Sohn EJ, Kim DW, Jeong HJ, Kim MJ, Kang HW, Shin MJ, Ahn EH, Kwon SW, Kim YN, et al. Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice. J Invest Dermatol 2011;131:1477-85. https://doi.org/10.1038/jid.2011.49